Kane Biotech Inc (OTCPK:KNBIF)
$ 0.097 0 (0%) Market Cap: 10.96 Mil Enterprise Value: 12.41 Mil PE Ratio: 4.33 PB Ratio: 0 GF Score: 37/100

Q3 2022 Kane Biotech Inc Earnings Call Transcript

Nov 24, 2022 / 09:30PM GMT
Operator

Good day and thank you for standing by. Welcome to the Kane Biotech Q3 2022 financial results conference call. (Operator Instructions) Please be advised that today's conference is being recorded.

I'd now like to hand the conference over to your first speaker today, to Nicole Sendey, Investor Relations. Please go ahead.

Nicole Sendey
Kane Biotech Inc. - Investor Relations

Thank you, operator. Good afternoon and welcome, everyone, to Kane Biotech's quarterly earnings conference call. We are delighted to have you join us today. This call will cover Kane's financial and operating results for the third quarter of 2022 along with a discussion of some of our recent highlights and goals for 2022 and beyond.

Following our prepared remarks, we'll open the conference call to a question-and-answer session. Our call today will be led by Kane's Chief Executive Officer, Marc Edwards.

Before we begin our formal remarks, I would like to remind everyone that some of the statements on this conference call do contain certain forward-looking

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot